IMDX vs STIM

IMDX exhibits severe financial distress, anchored by a Piotroski F-Score of 1/9, indicating critical weakness across nearly all fundamental health dimensions. The company suffers from negative equity (Price/Book: -2.89) and a catastrophic operating margin of -873.57%, suggesting an unsustainable business model. Revenue is contracting rapidly (-23.4% YoY), and the earnings track record is abysmal with 0 beats in the last four quarters. Despite optimistic analyst price targets, the deterministic data points toward a high risk of insolvency or significant further dilution.

STIM exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9 and a high Debt/Equity ratio of 3.44. While the company shows impressive top-line revenue growth of 85.70%, this is completely offset by a devastating ROE of -134.86% and consistent net losses. The combination of a 0/100 technical trend, bearish insider selling by the CEO and CFO, and a 62.2% one-year price decline suggests a high-risk profile. Despite bullish analyst targets, the deterministic health metrics indicate a company struggling for solvency.